Literature DB >> 19439145

Variability of joint communications in the foot and ankle demonstrated by contrast-enhanced diagnostic injections.

Michael R Carmont1, James E Tomlinson, Chris Blundell, Mark B Davies, David J Moore.   

Abstract

BACKGROUND: The history and physical examination will usually direct a surgeon to the correct site of joint pathology. Imaging with plain radiographs and diagnostic injections help localize joint pathology more precisely. The presence of accessory communications between adjacent joints may reduce the sensitivity of these investigations.
MATERIAL AND METHODS: We report on the findings of 389 arthrograms of the midfoot, hindfoot and ankle that were performed by a single radiologist over a 7-year period. Fluoroscopic guidance with radioopaque dye was used to confirm needle position before local anesthetic was injected. Images were closely studied to identify any communication between adjacent joints.
RESULTS: The passage of contrast into adjacent joints confirmed the presence of an additional communication. In 13.9% of cases there was a communication between the ankle and subtalar joint. A communication between the talonavicular and the calcaneocuboid joint was observed in 42.3% of local injections. We identified previously unreported communications between the anterior subtalar and the naviculocunieform joints (8%), the anterior subtalar and the calcaneocuboid joints (9%) and the naviculocunieform and tarsometatarsal joints (1.1%).
CONCLUSION: This study reinforces the typical incidence of known joint communications, describes previously unreported communications and highlights the importance of these communications particularly with the small joints of the midfoot. The possible presence of accessory communications must always be considered when performing isolated midfoot fusions relying upon diagnostic local anesthetic injections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439145     DOI: 10.3113/FAI-2009-0439

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  6 in total

Review 1.  Summary Report of the Arthritis Foundation and the American Orthopaedic Foot & Ankle Society's Symposium on Targets for Osteoarthritis Research: Part 1: Epidemiology, Pathophysiology, and Current Imaging Approaches.

Authors:  Jason S Kim; Annunziato Amendola; Alexej Barg; Judith Baumhauer; James W Brodsky; Daniel M Cushman; Tyler A Gonzalez; Dennis Janisse; Michael J Jurynec; J Lawrence Marsh; Carolyn M Sofka; Thomas O Clanton; Donald D Anderson
Journal:  Foot Ankle Orthop       Date:  2022-10-15

2.  Tarsometatarsal joint communication during fluoroscopy-guided therapeutic joint injections and relationship with patient age and degree of osteoarthritis.

Authors:  Yoshimi Endo; O Kenechi Nwawka; Shrita Smith; Jayme C Burket
Journal:  Skeletal Radiol       Date:  2017-11-07       Impact factor: 2.199

3.  Adjacent tissue involvement of acute inflammatory ankle arthritis on magnetic resonance imaging findings.

Authors:  Kyoung Min Lee; Chin Youb Chung; Sung Hun Won; Seung Yeol Lee; Young Choi; Moon Seok Park
Journal:  Int Orthop       Date:  2013-05-25       Impact factor: 3.075

4.  Can diagnostic injections predict the outcome in foot and ankle arthrodesis?

Authors:  Mark Stegeman; Berbke To Josephine van Ginneken; Bastiaan Boetes; Mirjam Tuinhout; Jan Willem Karel Louwerens; Bartele Alexander Swierstra
Journal:  BMC Musculoskelet Disord       Date:  2014-01-09       Impact factor: 2.362

Review 5.  Technetium-99m Methylene Diphosphonate Single-photon Emission Computed Tomography/Computed Tomography of the Foot and Ankle.

Authors:  Bhavin Upadhyay; Jonathan Mo; Clare Beadsmoore; Tom Marshall; Andoni Toms; John Buscombe
Journal:  World J Nucl Med       Date:  2017 Apr-Jun

Review 6.  Fluoroscopic-guided procedures of the lower extremity.

Authors:  Gunjan Malhotra; Barry G Hansford; Cindy Felcher; Kristie A Wuerfel; Corrie M Yablon
Journal:  Skeletal Radiol       Date:  2022-08-05       Impact factor: 2.128

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.